98 results
Page 4 of 5
6-K
5269x 8sai
15 Jan 20
Current report (foreign)
8:35pm
6-K
EX-99.2
l5ounj felmfjnoq07
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.1
8f0j5ub1io6bm
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.2
bdy8rlz3x utz2f4v
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
F-3
EX-4.1
r23tnr z14
7 Aug 19
Shelf registration (foreign)
8:24am
F-3
7rr80w3q056qc
7 Aug 19
Shelf registration (foreign)
8:24am
424B5
51hwoybu6m7le 9ovz3
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
y98 xrjtmi4
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.2
qpgcj0jp6
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-3.1
a87vy99gf 7bo
20 May 19
Current report (foreign)
5:28pm
6-K
EX-99.2
qlct8vgove6ctikz7
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.2
ufkjgv9v 0lh6q
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
0aryrvz l2u62
28 Sep 18
Current report (foreign)
8:40am
6-K
EX-99.2
yf645af
8 Aug 18
Index to Unaudited Consolidated Interim Financial Statements
7:00am
6-K
7pv6ksve
25 Jul 18
Current report (foreign)
8:21am
6-K
3h7ddu8jif 5zl
6 Jul 18
Current report (foreign)
7:42am
424B5
6szfieczq5fz je
20 Jun 18
Prospectus supplement for primary offering
5:32pm
424B5
c2o56ggcvv0y on4of1
18 Jun 18
Prospectus supplement for primary offering
9:15pm